Discover
DCOY
Decoy Therapeutics Inc.
3.87
1 x 3.73
6 x 4.40
bid
ask
-
0.04
1.02%
1 @ 04:00 PM
3.87 +0.00 (0.00%)
| Ytd | -50.32% | |
| 1y | -96.22% |
3.74
day range
4.07
3.51
52 week range
106.20
| Open | 3.87 | Prev Close | 3.91 | Low | 3.74 | High | 4.07 | Mkt Cap | 2.06M |
| Vol | 47.20K | Avg Vol | 251.74K | EPS | -112.73 | P/E | -0.03 | Forward P/E | N/A |
| Beta | 0.64 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 5.87 | 200-d Avg | 9.85 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 2.28M | ||
| Research and Development Expense | 749.81K | ||
| Selling, General and Administrative Expense | 1.53M | ||
| Operating Income | -2.28M | ||
| Net Income | -2.22M | ||
| Net Income Common Stock | -2.22M | ||
| Net Income Common Stock (USD) | -2.22M | ||
| Consolidated Income | -2.22M | ||
| Earnings per Basic Share | -4.18 | ||
| Earnings per Basic Share (USD) | -4.18 | ||
| Earnings per Diluted Share | -4.18 | ||
| Earning Before Interest & Taxes (EBIT) | -2.22M | ||
| Earning Before Interest & Taxes (USD) | -2.22M | ||
| Weighted Average Shares | 531.97K | ||
| Weighted Average Shares Diluted | 531.97K | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.82M | ||
| Cash and Equivalents (USD) | 7.82M | ||
| Current Assets | 8.36M | ||
| Property, Plant & Equipment Net | 35.74K | ||
| Total Assets | 8.42M | ||
| Current Liabilities | 4.55M | ||
| Total Liabilities | 4.55M | ||
| Accumulated Retained Earnings (Deficit) | -96.67M | ||
| Shareholders Equity | 3.88M | ||
| Shareholders Equity (USD) | 3.88M | ||
| Assets Non-Current | 65.62K | ||
| Deferred Revenue | 3.23M | ||
| Trade and Non-Trade Payables | 1.08M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.92K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.89M | ||
| Net Cash Flow from Operations | -2.89M | ||
| Share Based Compensation | 213.04K | ||